MYLAN LAB INC has a total of 59 patent applications. Its first patent ever was published in 2005. It filed its patents most often in China, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are DOSPHARMA, LAMELLAR THERAPEUTICS LTD and LIPID PHARMACEUTICALS EHF.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 7 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Canada | 6 | |
#4 | African Regional Industrial Property Organization | 4 | |
#5 | Australia | 4 | |
#6 | Israel | 4 | |
#7 | Republic of Korea | 4 | |
#8 | New Zealand | 4 | |
#9 | Singapore | 4 | |
#10 | United States | 4 | |
#11 | WIPO (World Intellectual Property Organization) | 4 | |
#12 | South Africa | 4 | |
#13 | Brazil | 1 | |
#14 | Hong Kong | 1 | |
#15 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Davis Eric | 18 |
#2 | Bottini Peter Bruce | 16 |
#3 | O'Donnell John P | 16 |
#4 | O'Donnell John | 15 |
#5 | Owens Walter | 12 |
#6 | Duncan Joseph | 12 |
#7 | Shaw Andrew | 12 |
#8 | Mason Preston | 9 |
#9 | Andrew Shaw | 7 |
#10 | Walter Owens | 6 |
Publication | Filing date | Title |
---|---|---|
US2014275242A1 | Hot melt granulation formulations of poorly water-soluble active agents | |
CA2637979A1 | Treatment of cardiovascular disease in mexican americans using nebivolol | |
CA2596428A1 | Glucuronidated nebivolol_metabolites | |
AU2006210952A1 | Pharmaceutical composition comprising hydroxylated nebivolol | |
CN101146528A | Pharmaceutical composition comprising hydroxylated nebivolol | |
CN101242827A | Compositions comprising nebivolol | |
SG162734A1 | Compositions comprising nebivolol | |
CN101022791A | Compositions comprising nebivolol |